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Abstract 
Objectives  
To compare image quality and radiation dose of right adrenal vein (RAV) imaging 
computed tomography (CT) among conventional, low kV, and low kV with reduced 
contrast medium protocols. 
Methods 
One-hundred-and-twenty patients undergoing adrenal CT were randomly assigned to 
one of three protocols: contrast dose of 600 mgI/kg at 120-kV tube voltage setting 
(600-120 group), 600 mgI/kg at 80 kV (600-80 group), and 360 mgI/kg at 80 kV 
(360-80 group). Iterative reconstruction was used for 80-kV groups. Signal-to-noise 
ratio (SNR) and contrast-to-noise ratio (CNR) of the RAV and size-specific dose 
estimates (SSDE) were measured. Three radiologists evaluated 4-point visualisation 
scores of RAV by consensus reading. 
Results 
The RAV detectability was 95%, 97.2%, and 97.3% for 600-120, 600-80, and 360-80 
groups, respectively (p = 1.000). Visualisation scores were not significantly different 
among the groups (p = 0.152). There were no significant differences in CNR or SNR 
between the 600-120 and 360-80 groups. SSDE of the 360-80 group was significantly 
lower than that of the 600-120 group (5.86 mGy ± 1.44 vs. 7.27 mGy ± 1.81, p < 
0.001). 
Conclusions 
80-kV scans with 360 mgI/kg contrast media showed comparable detectability of RAV 
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to conventional scans, while reducing 19% of SSDE. 
 
Keywords 
Hyperaldosteronism, Multidetector computed tomography, Contrast media, Low tube 
voltage CT, Adrenal glands. 
 
Abbreviations 
AP+LAT  the sum of anteroposterior length and lateral width 
AVS   adrenal vein sampling 
CI-AKI  contrast-induced acute kidney injury 
CNR  contrast-to-noise ratio 
CTDIvol  the volume CT dose index 
DLP   dose-length product 
FBP   filtered back projection 
IR   iterative reconstruction 
MDCT  multidetector computed tomography 
RAG   right adrenal grand 
RAV   right adrenal vein 
ROI  region of interest 
SNR  signal-to-noise ratio 
SSDE   size-specific dose estimate 
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Introduction 
Adrenal vein sampling (AVS) is considered the gold standard for diagnosis of 
primary aldosteronism (PA) [1]. To discuss the treatment strategy for PA, it is important 
to distinguish unilateral hyperaldosteronism from bilateral hyperaldosteronism. 
Therefore, successful AVS is required. However, AVS is technically challenging, 
especially in the right side because the right adrenal vein (RAV) is small and there are 
anatomical variations [2]. 
Contrast-enhanced multidetector computed tomography (MDCT) is used for the 
identification of RAV prior to AVS, and multiphase dynamic computed tomography 
(CT) examinations provide excellent detectability of RAV [3–5]. However, 
contrast-enhanced CT holds risks of radiation exposure and iodine-contrast–induced 
adverse side effects [6–8]. Contrast-induced acute kidney injury (CI-AKI) is a serious 
complication of iodinated contrast media [9]. Although the incidence of CI-AKI is low, 
it has been reported that patients with renal impairment or diabetes have increased risk 
of CI-AKI [10]. As for percutaneous coronary intervention, contrast media dose is a risk 
factor of acute kidney injury [11, 12]. However, several studies have reported that 
intravenous contrast media is not associated with acute kidney injury among patients 
with normal renal function [13, 14]. In the guidelines of the European Society of 
Urogenital Radiology, estimated glomerular filtration rate (eGFR) less than 45 
ml/min/1.73 m2 is considered as a risk factor of CI-AKI and even limited doses of 
contrast media may cause CI-AKI in high-risk patients [15]. Previous studies have 
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reported that PA was associated with glomerular hyperfiltration, which was unmasked 
after treatment of aldosterone excess along with normalised blood pressure [16, 17]. PA 
patients with apparently normal kidney function have potential of declines in eGFR 
after treatment of PA [16]. Therefore, it would be reasonable to reduce the amount of 
iodine contrast media for evaluation of RAV prior to AVS even if eGFR exceeded 60 
ml/min/1.73 m2.  
Recent clinical studies have suggested that low-tube-voltage imaging enables 
radiation dose reduction. Moreover, using low tube voltage results in higher iodine 
contrast enhancement and enables dose reduction of contrast media [18, 19]. Although 
low-tube-voltage imaging raises noise and decreases image quality, iterative 
reconstruction (IR) technique yields higher signal-to-noise ratio (SNR) and 
contrast-to-noise ratio (CNR) and provides better image quality than the standard 
filtered back projection (FBP) [20]. Low-tube-voltage CT imaging can be applied 
without deterioration of image quality to large vessels, medium-sized vessels, and 
parenchymal organs [21–27]. However, it has not been proven whether 
low-tube-voltage CT imaging is also applicable for imaging of small venous structures 
such as RAV. 
The purpose of this study was to compare RAV detectability and radiation doses 
among conventional and low-tube-voltage CT imaging protocols. 
 
Materials and Methods 
This prospective randomised study received institutional review board approval in 
7 
 
our institution, and informed consent was obtained from all participating patients. 
 
Patient population 
Between February 2015 and August 2016, 120 patients with known or suspected 
PA were consecutively enrolled. They were referred for MDCT examinations for 
evaluation of adrenal lesions and mapping of adrenal veins prior to AVS. The exclusion 
criteria were any of the following: (1) estimated glomerular filtration rate of <60 
ml/min/1.73 m2 and (2) a history of allergic reaction to iodine contrast media.  
 
MDCT protocol 
All patients underwent CT using a dual-source MDCT scanner (SOMATOM 
Definition Flash, Siemens Healthcare, Forchheim, Germany) with a single-source 
acquisition mode. Patients were randomly assigned to one of three protocols: contrast 
dose of 600 mg iodine/kg body weight at conventional 120-kV tube voltage setting 
(600-120 group), 600 mg at 80 kV (600-80 group), and 360 mg at 80 kV (360-80 group). 
We generated a random number table using the RAND function in Excel 2013 
(Microsoft, Seattle, WA) for patient randomisation. Referring to a previous study 
demonstrating RAV detectability of 93% [3], we performed power analysis assuming 
that the detectability of RAV by both the conventional and low-kVp protocols were 93% 
and we established the limit of the non-inferiority test to 15%. The required number of 
cases calculated with detection power of 80% and significance level of 5% was 36 cases 
per group. Considering inappropriate cases, we assigned 40 cases to each group. All 
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images were reconstructed with filtered back projection (FBP). In the 80-kV setting, 
images were also reconstructed with IR (SAFIRE Strength 3, Siemens). We applied 
SAFIRE strength 3 which was routinely used for cardiovascular and body CT imaging 
at low kVp protocols. Quality reference mAs was set at 90 mAs in the 120-kV setting. 
In the 80-kV setting, it was automatically regulated to obtain almost the same image 
quality obtained from the 120-kV setting by using CARE kV technique. CARE kV 
technique can automatically suggest kV and effective mAs to optimise the 
contrast-to-noise ratio (CNR). Effective mAs was automatically regulated with Auto 
Exposure Control. The detailed scanning parameters are shown in Table 1. 
Four-phase dynamic imaging was performed. The amount of nonionic contrast 
material administered via bolus injection was 600 or 360 mg iodine/kg body weight. 
One of the following contrast media was selected and injected at a speed of 3-5 ml/s: 
iohexol (240 mg iodine/ml in 100-ml syringe [Omnipaque 240, Daiichi-Sankyo, Tokyo, 
Japan], 300 mg iodine/ml in 100-ml and 150-ml syringes [Omnipaque 300, 
Daiichi-Sankyo], and 350 mg iodine/ml in 100-ml syringe [Omnipaque 350, 
Daiichi-Sankyo], 300 mg iodine/ml in 100-ml syringe [Iopaque 300, Fujipharma, 
Toyama, Japan]), iomeprol (300 mg iodine/ml in 100 ml syringe [Iomeron 300, Eisai, 
Tokyo, Japan]), or iopamidol (370 mg iodine/ml in 100-ml syringe [Iopamiron 370, 
Bayer Yakuhin, Osaka, Japan] and 300 mg iodine/ml in 100-ml syringe [Oypalomin 300, 
FujiPharma, Toyama, Japan]). However, injection speeds of <3 ml at 240 mgI/ml for 
lean patients (<50 kg) in the 360 mgI/kg group and that of >5 ml/s at 300 mg/ml for 
obese patients (> 63 kg) in the 600 mgI/kg group were tolerated. In our clinical settings, 
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only one syringe of contrast medium was administered per examination. The maximum 
dose was 45 g of iodine. 
The injection time was fixed to 25 s and the injection speed was changed 
accordingly. The scan delay was set using an automatic triggering system. Early-arterial 
phase (1st phase) scanning automatically started when the attenuation value at the 
abdominal aorta reached a preset threshold (CT value on native CT plus 50 Hounsfield 
Units). Late-arterial phase (2nd phase) scanning started 13 s after the 1st phase 
completion. Venous phase (3rd phase) and delayed phase (4th phase) scanning began at 
70 s and 3 min after contrast injection initiation, respectively. 
 
Radiation dose 
The volume CT dose index (CTDIvol) and dose-length product (DLP) values 
provided by the CT scanner were recorded for each examination. We calculated 
size-specific dose estimates (SSDE) values according to the AAPM (American 
Association of Physicists in Medicine) Report 204 [28]. The sum of the lengths of the 
body in the anteroposterior and lateral directions at the level of adrenal glands 
(AP+LAT) was measured and conversion factors were obtained from the table in that 
report. Maximum and minimum effective mAs of scans were also recorded. 
 
CT image interpretation 
Three radiologists with experience of body radiology for 15 years 
(board-certificated), 5 years, and 5 years, respectively, performed image analysis. Scan 
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protocols and patient’s information were blinded. If the RAV identification was 
indeterminate, two of the radiologists, including a board-certificated radiologist, 
evaluated the images together to reach consensus. We adjusted the window width/level 
to 300/150-200 to properly discriminate the RAV from surrounding structures. 
To evaluate image contrast, the mean CT attenuation values and the standard 
deviation (SD) of the RAV, the right adrenal gland parenchyma (RAG), and the 
subcutaneous fat of the anterior abdominal wall at the same level as the RAG were 
measured in the circular or square region-of-interest (ROI) of approximately 2, 10, and 
100 mm2, respectively. These measurements were performed in the axial image of the 
2nd phase because a previous study reported that RAV was best visualised in the 2nd 
phase [29]. Image noise was defined as the SD of the attenuation values of the 
subcutaneous fat. To minimise bias from single measurements, mean values of three 
different ROIs in different axial images were calculated. On RAV measuring, ROIs 
adjacent to each other were set when different axial images could not be chosen. For 
calculation of signal-to-noise ratio (SNR), SDs of CT attenuation values were also 
measured in each ROI. SNR was calculated by dividing the mean CT attenuation values 
by mean SDs of RAV. The CNR was also calculated as CNR = (the attenuation values of 
RAV − the attenuation values of RAG)/image noise. In the 80-kV groups, we measured 
CT attenuation values and SDs both in FBP and IR reconstructed images. 
The degree of RAV visualisation was recorded using a 4-point scale according to a 
previous report [3]. A score of 4 indicates excellent visualisation: the RAV has strong 
contrast compared to surrounding structures and clearly visualised. A score of 3 
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indicates good visualisation: although the RAV is detectable with accuracy, it is not 
clearly visualised because of its smallness or poor contrast. A score of 2 means poor 
visualisation: the RAV is equivocally detected with minimal contrast. A score of 1 
means no visualisation: the RAV is not visualised. A score of 4 and 3 was defined as a 
detectable RAV. In 80-kV groups, visualisation scores were evaluated in IR images. For 
comparison with previous studies, the phase at which RAV was best visualised and the 
presence of common trunk were also recorded. 
 
Statistical analysis 
Statistical analyses were performed with EZR (Saitama Medical Centre, Jichi 
Medical University, Saitama, Japan), which is a graphical user interface for R (The R 
Foundation for Statistical Computing, Vienna, Austria) [30]. All numerical data are 
shown as the mean ± SD. Continuous variables were checked its normality using the 
Kolmogorov-Smirnov test. Data among three groups with normality were compared by 
one-way analysis of variance (ANOVA) with Tukey’s method for post hoc comparisons 
and those without normality were compared by the Kruskal-Wallis test with the 
Steel-Dwass test for post hoc comparisons. Detectability and visualisation scores were 
compared using Fisher’s exact tests. Mann-Whitney U tests were used in the subgroup 
analyses. A p < 0.05 was considered as statistically significant. 
 
Results 
Patient backgrounds 
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Four patients assigned to the 600-80 group and three patients to the 360-80 group 
were excluded from this study because they were imaged with different scan pitch 
and/or kV setting. Table 2 shows the patient characteristics in the three groups; they 
were not significantly different among the three groups.  
 
Qualitative image analysis 
The overall RAV detectability in the 120 patients was 96.5%: 95.0% in the 
600-120 group (38/40), 97.2% in the 600-80 group (35/36), and 97.3% in the 360-80 
group (36/37). The visualisation scores are shown in Table 3. There were no significant 
differences among the three groups. 
RAVs were best visualised mostly in the 2nd phase: 105 in the 2nd phase (92.9%) and 
4 in the 3rd phase (3.5%). The representative RAV images in the three groups are shown 
in Figure 1. In 4 patients (3.5%), the RAV was not clearly identified. All visualised 
RAVs could be detected in the 2nd phase. In 21 patients (18.6%), common trunk of 
RAV and an accessory hepatic vein were identified. Maximum intensity projection and 
volume rendering views of the RAV as well as catheter venography are shown in figure 
2. 
 
 
Quantitative image analysis  
Table 4 shows the results of the quantitative image analysis. Background noise 
(SD of the CT attenuation values of subcutaneous fat) of the 600-120 group was 
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significantly higher than those measurements in IR images of the other two groups (p < 
0.001 for both). CT attenuation values of the RAV and the RAG in the 600-80 group 
were significantly higher than those of the other two groups and there was no significant 
difference between the 600-120 group and the 360-80 group. The SNR and CNR of the 
three groups showed the similar results when FBP images in the 600-120 group and IR 
images in the 80-kV setting groups were compared.  
When FBP and IR images of the 80-kV groups were compared, SDs of FAT, RAG, 
and RAV in IR images were approximately 30% lower than those in FBP images (p < 
0.001 for all comparisons); in contrast, CT attenuation values showed little difference 
between FBP and IR images. Consequently, SNR and CNR in IR images were higher 
than those in FBP (600-80 group: p < 0.001, p = 0.027, respectively, 360-80 group: p < 
0.001, p = 0.351, respectively). 
 
Iodine intake and radiation dose 
Mean iodine intakes were as follows: 38.2 (range 16.2–45.0) g in the 600-120 
group, 38.4 (range 26.4–45.0) g in the 600-80 group, and 23.8 [range 13.7–40.3] g in 
the 360-80 group. Twenty-three patients (13 in the 600-120 group and 10 in the 600-80 
group) took maximal iodine dose of 45 g, which was 11.9% ± 7.3% [range 1.3%–
26.5%] less than 600 mgI/kg body weight. Scatter plots of administered contrast media 
dose and CT attenuation values of RAV and CNR in the 600-120 and 600-80 groups are 
shown in figure 3. Dividing patients into low iodine subgroup (iodine intake < 45 g) and 
maximal iodine subgroup (iodine intake = 45 g), CNR in the 600-80 group was 
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significantly lower in maximal iodine subgroup than that in low iodine subgroup 
(Mann-Whitney U test: p = 0.017); other variables in maximal iodine subgroups tended 
to be lower than those in low iodine subgroups (CNR in the 600-120 group, CT 
attenuation values of RAV in the 600-120 group and that in the 600-80 group; p = 0.283, 
p = 0.243 and p = 0.070, respectively). Visualisation score and detectability showed no 
significant difference (Fisher’s exact test: p = 0.554 and p = 1.000, respectively). 
Among different concentrations of contrast media, there were no significant differences 
in visualisation score, CT attenuation values of the RAV, SNR or CNR. 
Table 4 also shows radiation dose parameters. The CTDI and SSDE of the 360-80 
group were significantly lower than those of the 600-120 group (p = 0.033 and p < 
0.001, respectively). The CTDI and SSDE of the 600-80 group were lower than those of 
the 600-120 group; however, significant differences were not observed. The AP+LAT 
values among three groups were not significantly different. Figure 4 shows scatter plots 
between SSDE and AP+LAT values. These parameters showed positive correlations 
across the entire distribution in the 120-kV group (r = 0.896, p < 0.001). However, in 
the 80-kV groups, SSDE values showed a descending slope distribution among subjects 
with AP+LAT values > 55. 
In the 600-80 group and the 360-80 group, 18/19 patients (95%) with AP+LAT 
values > 55 cm reached maximal effective mAs of 322 mAs. After categorising patients 
into one of these two subgroups: a low-current subgroup, in which effective mAs did 
not reach 322 mAs and a high-current subgroup, in which effective mAs reached 
maximal 322 mAs, it was observed that the low-current subgroup showed positive 
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correlation and the high-current group showed negative correlation between AP+LAT 
values and SSDE (r = 0.842, p < 0.001 for the low-current 600-80 subgroup; r = 0.571, 
p = 0.002 for the low-current 360-80 subgroup, r = -0.712, p = 0.003 for the 
high-current 600-80 subgroup; and r = -0.876, p < 0.001 for the high-current 360-80 
subgroup). Visualisation score and detectability showed no significant difference among 
the low-current and high-current subgroups (Fisher’s exact test: p = 1.000 and p = 1.000, 
respectively). 
 
Discussion 
The RAV detectability in our three groups was high and comparable to that of 
previous studies [3–5, 29]. Our study demonstrated that 80 kV and 360 mgI/kg contrast 
media protocol (the 360-80 group) showed no significant difference in the detectability 
of RAV compared with the conventional protocol (the 600-120 group). Despite the 40% 
lower dose of contrast media, the CT attenuation values of the RAV and the RAG of the 
360-80 group were comparable to those of the 600-120 group. Using IR, SNR and CNR 
were increased along with reductions of SDs of CT attenuation values. The RAV 
detectability between the two groups was not significantly different. The SSDE of the 
360-80 group was 19% lower than that of the 600-120 group. The 80-kV setting with IR 
was useful in radiation dose reduction while keeping the image quality.  
Recent clinical studies on low-kV CT have suggested that low-KV setting CT 
scanning with iterative reconstruction and using low dose of contrast media had 
maintained image quality for lesion detection as well as assessment of arteries and large 
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veins. A total of 30–50% reduction of contrast media was achieved in low-kV settings 
without decreasing diagnostic accuracy [21, 24, 26, 31, 32]. The present study showed 
the usefulness of low-kV imaging with low-dose contrast media on imaging of small 
veins such as the RAV. Dual-energy CT is another way to reduce radiation and contrast 
media dose. Using virtual monochromatic images obtained by dual-energy CT, more 
appropriate contrast enhancement may be achieved and further reduction of contrast 
media may be possible [33]. A study using dual-energy CT is worth pursuing in the 
future. 
SSDE showed negative correlation in the 600-80 group and the 360-80 group 
when AP+LAT values were over 55 cm, due to limitation of tube current (322 mAs) in 
our 80-kV scan protocols. However, based on our results that the RAV detectability was 
not degraded in larger subjects in the low-kV group, excess radiation was not required. 
Furthermore, it may be possible to reduce the tube current in smaller body subjects 
more than the present low kV scan protocol without degrading the RAV detectability. 
We performed 4-phase dynamic imaging to evaluate appropriate scan delay for 
RAV visualisation as well as to characterise adrenal lesions. Based on our results and 
those of a previous study [29], the dynamic phases may be limited to 2nd and 3rd ones 
for the purpose of RAV detection to avoid excess radiation exposure in both the 80-kV 
and 120-kV protocols. It is known that 7–24% of the RAVs share the venous trunk with 
an accessory hepatic vein [3–5]. Ota et al. and Omura et al. reported that the 3rd phase 
best visualised this anatomical variant [3, 29]. Although evaluation of the anatomical 
variants was beyond the scope of our study, it will be recommended to include the 3rd 
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phase not to miss cases with common trunk and/or RAV best visualised in the 3rd phase. 
It is known that 20 % of RAV shares a common trunk with an accessory hepatic vein 
[29, 34]. 
Our study has limitations. First, our patient population included only a small 
number of large body patients (AP+LAT > 55 cm). Although the result of this study 
showed no significant difference in the RAV detectability among body size, it may be 
important to study large body patients. Second, 23 patients did not receive the full dose 
of 600 mgI/kg in the 600-120 group and the 600-80 group due to the limitation of 45 g 
iodine per syringe. Although their CT attenuation value of the RAV and CNR tended to 
be lower than that of other patients who were administered 600 mgI/kg, there were no 
significant difference in the visualisation score and the detectability of the RAV. Further 
study about appropriate dose of contrast media is required. 
In conclusion, the image quality of RAV MDCT imaging at 80 kV with 360 mg/kg 
iodine contrast media using iterative reconstruction was comparable to that of the 
setting at 120 kV with 600 mg/kg iodine contrast media. This protocol significantly 
reduced both iodine and radiation doses. 
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Figure legends 
 
Fig.1―Representative image of the right adrenal vein (RAV). Axial images and oblique 
sagittal images of the 600-120 group (A and D), the 600-80 group (B and E), and the 
360-80 group (C and F) are shown (window width = 300 HU and window level = 150 
HU). The RAV is visualised clearly in all images (arrow). The 600-80 group shows 
stronger contrast than the other two groups. The 600-120 group and the 360-80 group 
show similar contrast. Image noise of both the 600-80 group and the 360-80 group was 
decreased with iterative reconstruction. 
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Fig.2― Second phase CT images (A-C) and subsequently performed catheter 
venography (D) of a patient in the 360-80 group. The right adrenal vein (arrows) are 
shown on axial image (A), maximum intensity projection image in right anterior oblique 
(RAO) 60° view (B), VR image in RAO 30°view (C) and catheter venography in 
RAO 30° view (D). 
 
  
28 
 
Fig.3―Scatter plots of CT attenuation values of RAV and CNR on the vertical axis 
versus administered contrast media dose on the horizontal axis in the 600-120 (A and C) 
and the 600-80 groups (B and D).  
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Fig.4―The correlation between size-specific dose estimates (SSDE) and the sum of the 
lengths of the body in the anteroposterior and lateral directions at the level of adrenal 
glands (AP+LAT) in the three groups is shown. SSDE and AP+LAT values show almost 
proportional relationship. When AP+LAT values are 55 or more, SSDE shows 
descending slope distribution in the 600-80 group and the 360-80 group. Patients whose 
maximum effective mAs reached 322 mAs are represented with open dots. 
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Table 1. CT scan parameter 
 600-120 600-80 360-80 
Rotation time (s) 0.5 0.5 0.5 
Reconstruction kernel B35f B35f, I30f(3) B35f, I30f(3) 
Reconstructed slice 
 thickness/interval (mm) 
1/1 1/1 1/1 
Collimation (slice count × mm) 128×0.6 128×0.6 128×0.6 
Pitch 1.0 1.0 1.0 
tube voltage (kV) 120 80 80 
CARE kV setting semi 80 semi 80 semi 80 
maximum Effective mAs 48-202 135-322 89-322 
minimum Effective mAs 38-144 76-321 43-321 
contrast media injection (mgI/kg) 600* 600* 360 
reference mAs 90 #1 #1 
 
Effective mAs are the range. 
* Some patients with large body (> 75 kg) were not able to be administered full dose of 
600 mgI/kg due to the limitation dose of 45 g iodine per syringe. 
#1 Automatically regulated to obtain almost same level of image noise as 120 kV 
setting. 
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Table 2. Patient characteristics. 
 ALL 600-120 600-80 360-80 p-Value 
Number of patient 113 40 36 37  
Male (%) 55 (48.7) 21 (52.5) 17 (47.2) 12 (32.4) 0.193a 
Age (years)   50.4 ± 13.0   51.8 ± 13.3   52.3 ± 13.3   46.9 ± 11.8 0.142b 
weight (kg)   66.7 ± 16.1   67.5 ± 14.9   66.4 ± 13.7   66.2 ± 19.5 0.933b 
height (cm) 163.2 ± 9.2 164.7 ± 9.6 162.2 ± 8.2 162.5 ± 9.7 0.430b 
BMI (kg/m2)  24.8 ± 4.5  24.7 ± 4.0  25.1 ± 4.0  24.7 ± 5.5 0.919b 
eGFR (ml/min/1.73m2) 86.8 ± 19.2 85.7 ± 17.6 86.7 ± 22.3 87.9 ± 18.2 0.879b 
 
Data are shown as mean ± standard division (SD). eGFR: estimated glomerular filtration rate. 
a Fisher’s exact test 
b One-way analysis of variance test 
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Table 3. Visualisation score and detectability of right adrenal vein. 
 ALL 600-120 600-80* 360-80* p-Value 
4 (excellent) 98 35 34 29  
3 (good) 11 3 1 7  
2 (poor) 4 2 1 1  
1 (none) 0 0 0 0  
detectability 96.5 % 
(109/113) 
95 % 
(38/40) 
97.2 % 
(35/36) 
97.3 % 
(36/37) 
1a 
score 2.8 ± 0.5 2.8 ± 0.5 2.9 ± 0.4 2.7 ± 0.5 0.068b 
 
* Score of the 600-80 group and the 360-80 group ware evaluated in iterative 
reconstruction images. 
a Fisher’s exact test.  
b Kruskal-Wallis test.  
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table 4. Quantitative image analysis and radiation dose. 
 
BG: background, FAT: subcutaneous fat of the anterior abdominal wall, RAV: right adrenal vein, RAG: right adrenal grand, SNR: 
 A 
600-120 
FBP 
B 
600-80 
FBP 
C 
600-80 
IR 
D 
360-80 
FBP 
E 
360-80 
IR 
p-Value 
A vs C A vs E C vs E 
BG noise  23.6 ± 3.3  26.9 ± 3.7  18.8 ± 3.6  28.5 ± 4.9  19.6 ± 3.6 <0.001 <0.001  0.559 
RAV SD*  23.6 ± 7.6  40.9 ± 11.4  26.4 ± 9.6  31.2 ± 13.8  20.7 ± 7.6  0.307  0.314  0.013 
RAV HU (HU)* 209.9 ± 45.1 331.0 ± 65.5 337.5 ± 72.8 228.0 ± 58.3 228.2 ± 59.6 <0.001  0.390 <0.001 
RAG HU (HU)* 144.7 ± 21.4 231.9 ± 44.8 238.7 ± 48.1 159.5 ± 31.2 163.7 ± 33.6 <0.001  0.060 <0.001 
SNR*   9.7 ± 3.2   8.5 ± 2.2  14.2 ± 5.4   8.0 ± 2.3  12.1 ± 5.1 <0.001  0.023  0.153 
CNR*   2.6 ± 1.7   3.8 ± 1.8   5.3 ± 3.0   2.4 ± 1.5   3.2 ± 2.4 <0.001  0.572  0.001 
CTDI(L) (mGy)   5.1 ± 2.0 4.7 ± 1.3 4.1 ± 1.5  0.518  0.033  0.345 
AP+LAT (cm)  52.3 ± 6.4 52.0 ± 6.0 51.3 ± 8.0  0.980  0.782  0.889 
SSDE(L)(mSv)   7.3 ± 1.8 6.7 ± 1.4 5.9 ± 1.4  0.258 <0.001  0.102 
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signal-to-noise ratio, CNR: contrast-to-noise ratio, CTDI(L): the volume CT dose index of the late-arterial phase, AP+LAT: the sum of 
anteroposterior thickness and lateral width, SSDE(L): size-specific dose estimation of the late-arterial phase. 
Data are shown Mean ± SD. SNR were compared by the Kruskal-Wallis test and others were compared by one-way analysis of variance. 
Statistically significant data are shown in bold. 
Four patients (2 in 600-120 group, 1 in 600-80 group and 1 in 360-80 group) were excluded from measurements of parameters with 
asterisks because RAVs were not visualised.  
 
